A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin

NCT00000778 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Tuberculosis

Interventions

DRUG: Isoniazid
DRUG: Pyridoxine hydrochloride
DRUG: Levofloxacin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)